NCT07261449

Brief Summary

Tendinopathy is an inflammatory process that occurs in and around the tendon when both are affected by a certain injury. In the case of the supraspinatus muscle it is one of the most frequent causes of shoulder pain. To test the efficacy of laser treatment in reducing shoulder pain caused by supraspinatus muscle tendinopathy. A randomized controlled clinical trial (RCT) was carried out in which a physiotherapy intervention was performed using therapeutic laser for three months, to observe the influence on the pain generated by supraspinatus muscle tendinopathy in the shoulder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 12, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

November 22, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

painrange of motionquality of life

Outcome Measures

Primary Outcomes (1)

  • intensity of pain.

    measured using the VAS scale, where 0 is the least possible pain and 10 is the greatest possible pain

    3 months

Secondary Outcomes (2)

  • Range of motion

    3 months

  • Patient quality of life

    3 months

Study Arms (2)

Laser treatment

EXPERIMENTAL

Laser treatment on tendinophaty shoulder.

Device: Laser Group

Placebo Group

PLACEBO COMPARATOR

Placebo treatment on tendinophaty shoulder.

Device: Placebo Group

Interventions

Therapeutic laser treatment is performed on the shoulder.

Laser treatment

A placebo treatment is carried out on the shoulder, simulating the application of the laser.

Placebo Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Score of 3 or higher on the VAS scale for the shoulder.
  • Adequate cognitive ability for comprehension.
  • Rotator cuff tendinopathy confirmed by ultrasound at the study center, either due to tendon inflammation, presence of hypoechoic areas, calcification, fibrillar disorganization, and/or neovascularization in the supraspinatus muscle.
  • Pain in the proximal lateral part of the arm that worsens with abduction.

You may not qualify if:

  • Contraindications specific to laser treatment (e.g., tumors, presence of pacemaker or defibrillator, pregnancy, etc.).
  • History of glenohumeral fracture and rheumatoid arthritis.
  • Rheumatic, neurological, or structural polymyalgia affecting the joint.
  • Previous surgeries.
  • Pregnant or breastfeeding women.
  • Taking anticoagulants or antiplatelet agents.
  • Diabetes mellitus.
  • Cardiac dysfunction.
  • Infiltrative and/or rehabilitative treatment in the two months prior to recruitment.
  • Pre-existing conditions associated with pain in the upper extremities. Difficulties with follow-up.
  • Depression.
  • Treatment with another intervention; during the study, they will not be able to undergo it.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Pontificia de Salamanca

Salamanca, 37002, Spain

Location

Related Publications (5)

  • Redondo-Alonso L, Chamorro-Moriana G, Jimenez-Rejano JJ, Lopez-Tarrida P, Ridao-Fernandez C. Relationship between chronic pathologies of the supraspinatus tendon and the long head of the biceps tendon: systematic review. BMC Musculoskelet Disord. 2014 Nov 18;15:377. doi: 10.1186/1471-2474-15-377.

  • Haik MN, Alburquerque-Sendin F, Moreira RF, Pires ED, Camargo PR. Effectiveness of physical therapy treatment of clearly defined subacromial pain: a systematic review of randomised controlled trials. Br J Sports Med. 2016 Sep;50(18):1124-34. doi: 10.1136/bjsports-2015-095771. Epub 2016 Jun 10.

  • Romero-Morales C, Bravo-Aguilar M, Abuin-Porras V, Almazan-Polo J, Calvo-Lobo C, Martinez-Jimenez EM, Lopez-Lopez D, Navarro-Flores E. Current advances and novel research on minimal invasive techniques for musculoskeletal disorders. Dis Mon. 2021 Oct;67(10):101210. doi: 10.1016/j.disamonth.2021.101210. Epub 2021 Jun 4.

  • Asensio-Olea L, Leiros-Rodriguez R, Marques-Sanchez MP, de Carvalho FO, Maciel LYS. Efficacy of percutaneous electrolysis for the treatment of tendinopathies: A systematic review and meta-analysis. Clin Rehabil. 2023 Jun;37(6):747-759. doi: 10.1177/02692155221144272. Epub 2022 Dec 30.

  • Sanchez-Sanchez JL, Calderon-Diez L, Herrero-Turrion J, Mendez-Sanchez R, Arias-Buria JL, Fernandez-de-Las-Penas C. Changes in Gene Expression Associated with Collagen Regeneration and Remodeling of Extracellular Matrix after Percutaneous Electrolysis on Collagenase-Induced Achilles Tendinopathy in an Experimental Animal Model: A Pilot Study. J Clin Med. 2020 Oct 15;9(10):3316. doi: 10.3390/jcm9103316.

MeSH Terms

Conditions

TendinopathyPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
triple blinding
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 22, 2025

First Posted

December 3, 2025

Study Start

September 12, 2023

Primary Completion

July 24, 2024

Study Completion

June 12, 2025

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-identified individual participant data, including the data dictionary, will be shared with qualified researchers. The shared IPD will include the data needed to reproduce the study findings, such as the de-identified participant-level data underlying the results reported in the publication.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Currently and for 12 months.
Access Criteria
Upon request to the corresponding author.

Locations